Pharmacy Board of Australia - Search
Look up a health practitioner

Close

Check if your health practitioner is qualified, registered and their current registration status
88 search results for
  • October 2014

    Pharmacy Board
    The Notifications Committee considered an increased number of notifications frequently involving complex situations. ... Methotrexate incidents. In recent months, the
    Date published 26 September 2023
    www.pharmacyboard.gov.au/News/Newsletters/October-2014.aspx
  • Research, strategy and policy

    Australian Health Practitioner Regulation Agency
    a review of notifications about pharmacists involving the dispensing of oral methotrexate.
    Date published 1 January 2011
    www.ahpra.gov.au/Publications/Annual-reports/Annual-Report-2020/Research-strategy.aspx
  • March 2021

    Pharmacy Board
    Methotrexate is an anti-inflammatory drug. It is also a cytotoxic used in cancer chemotherapy. ... Support from a senior colleague may be helpful. The Board has also…
    Date published 26 September 2023
    www.pharmacyboard.gov.au/News/Newsletters/March-2021.aspx
  • Results match 2 of 3 terms

  • Court and tribunal decisions

    Australian Health Practitioner Regulation Agency
    A nurse has been disqualified and prohibited for 12-months for obtaining and mishandling drugs including fentanyl, incorrect records, breaching conditions of his registration …
    Date published 9 May 2024
    www.ahpra.gov.au/Resources/Tribunal-decisions.aspx
  • Aboriginal and Torres Strait Islander Health Strategy Unit

    Australian Health Practitioner Regulation Agency
    Indigenous and non-Indigenous members to decide upon notifications and compliance matters involving Aboriginal and Torres Strait Islander notifiers and practitioners.
    www.ahpra.gov.au/Health-Strategy-Unit.aspx
  • Media release

    Australian Health Practitioner Regulation Agency
    We can best ensure that by involving the community in the planning, implementation and delivery of the scheme,’ said Mr Laris.
    Date published 20 May 2013
    www.ahpra.gov.au/News/2013-05-20-media-release.aspx
  • Gender based restrictions & chaperone protocol

    Australian Health Practitioner Regulation Agency
    This included the increased use of gender-based restrictions for matters involving allegations of sexual misconduct.
    Date published 3 February 2023
    www.ahpra.gov.au/Registration/Monitoring-and-compliance/Chaperone-Protocol.aspx
  • Shared Code of conduct

    Australian Health Practitioner Regulation Agency
    investigation, providing treatment (this may not be possible in an emergency), or involving patients in teaching or research.
    Date published 29 June 2022
    www.ahpra.gov.au/Resources/Code-of-conduct/Shared-Code-of-conduct.aspx
  • Analysis of notifications involving oral methotrexate – summary report published

    Pharmacy Board
    Dose administration aids. The Board and other stakeholders publish case studies from time to time, including about errors involving methotrexate. ... The Board will continue…
    Date published 24 March 2021
    www.pharmacyboard.gov.au/News/2021-03-24-summary-report-published.aspx
  • Tribunal reprimands pharmacist for unsafe dispensing

    Australian Health Practitioner Regulation Agency
    In January 2015, pharmacist Jennifer Barca dispensed an unsafe dose of methotrexate to a patient who subsequently died from complications of methotrexate toxicity. ... A…
    Date published 1 January 2001
    www.ahpra.gov.au/News/2021-01-22-Tribunal-reprimands-pharmacist.aspx
Displaying results 1 to 10 of 88
 
Page reviewed 28/07/2015